Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PYXIS ONCOLOGY, INC.

(PYXS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Limping in Late Trade

10/08/2021 | 03:57pm EST


ę MT Newswires 2021
All news about PYXIS ONCOLOGY, INC.
11/19INSIDER BUY : Pyxis Oncology
MT
11/15PYXIS ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
11/15Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Upd..
AQ
11/10Pyxis Oncology to Present at the Jefferies London Healthcare Conference
AQ
11/02Credit Suisse Starts Pyxis Oncology at Outperform with $19 PT on Potential of Antibody-..
MT
11/02Jefferies Starts Pyxis Oncology at Buy with $25 Price Target
MT
11/02BofA Securities Starts Pyxis Oncology at Neutral With $16 Price Target
MT
10/18INSIDER BUY : Pyxis Oncology
MT
10/11PYXIS ONCOLOGY, INC.(NASDAQGS : PYXS) added to NASDAQ Composite Index
CI
10/08Health Care Limping in Late Trade
MT
More news
Analyst Recommendations on PYXIS ONCOLOGY, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -69,6 M - -
Net cash 2021 271 M - -
P/E ratio 2021 -4,18x
Yield 2021 -
Capitalization 414 M 414 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 45
Free-Float 85,1%
Chart PYXIS ONCOLOGY, INC.
Duration : Period :
Pyxis Oncology, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PYXIS ONCOLOGY, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 12,84 $
Average target price 23,00 $
Spread / Average Target 79,1%
EPS Revisions
Managers and Directors
Lara S. Sullivan Chief Executive Officer & Director
Pamela Yanchik Connealy Chief Financial Officer
David Steinberg Chairman
Steve Monks Chief Technical Officer
Jay Feingold Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PYXIS ONCOLOGY, INC.0.00%414
GILEAD SCIENCES, INC.20.61%88 146
BIONTECH SE326.89%84 049
REGENERON PHARMACEUTICALS33.17%67 266
WUXI APPTEC CO., LTD.24.40%64 416
VERTEX PHARMACEUTICALS-22.32%46 678